Owkin

News

Owkin signs up another pharma partner for its AI platform

France’s Servier has become the latest pharma group to tap into an artificial intelligence platform for drug discovery, development, and diagnostics developed by Franco-US

News

ASCO: AI-powered MOSAIC will build 3D atlas for cancer

In amongst the big clinical trial readouts at ASCO, a new research project made its official debut with the ambitious goal of mapping cancer cells’ interactions with their

Digital

Owkin cofounders CEO Dr Thomas Clozel and CSO Gilles Wainrib, PhD.

Owkin taps Linux Foundation to open-source its AI learning s...

Just a few months after publishing the results of a project wherein they convinced ten competing pharma companies to give the same AI access to their data sets, life sciences AI specialist

Views & Analysis

AI diagnostics tools and oncology: predicting patient outcom...

AI French-American biotech start-up Owkin recently published new research in

News

jason-rosewell-voice-microphone-child-unsplash

Could cancer be diagnosed from the sound of a voice?

A $14 million research project is getting underway in the US to see whether cancer and other diseases can be diagnosed by picking up subtle changes in a person's voice patterns.

Digital

AI tissue analysis enables rapid discovery of drug candidate...

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient gr

Owkin signs up another pharma partner for its AI platform

ASCO: AI-powered MOSAIC will build 3D atlas for cancer

Owkin taps Linux Foundation to open-source its AI learning s...

AI diagnostics tools and oncology: predicting patient outcom...

Could cancer be diagnosed from the sound of a voice?

AI tissue analysis enables rapid discovery of drug candidate...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Owkin

Editor's Picks